abrdn plc Invests $1.17 Million in TScan Therapeutics, Inc. (NASDAQ:TCRX)

abrdn plc acquired a new stake in TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm acquired 200,000 shares of the company’s stock, valued at approximately $1,166,000. Separately, Pale Fire Capital SE bought a new stake in shares of TScan Therapeutics during the 3rd quarter valued at $42,000. […]

Related Keywords

United States , ,Tscan Therapeutics Inc ,Nasdaq ,Holdings Channel ,Free Report ,Pale Fire Capital ,Get Free Report ,Visit Holdingschannel ,Therapeutics Daily ,Tscan Therapeutics ,Nasdaq Tcrx ,Tcrx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,